Filings
Finds words inside filing documents. Searching CytomX Therapeutics, Inc.'s filings · 28 documents indexed.
7 documents · 26 matches
-
CTMX CytomX Therapeutics, Inc. 10-Q 2026-11-05
Item 1A. Risk Factors
material weaknesses. A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that3 matches in this document -
CTMX CytomX Therapeutics, Inc. 10-Q 2026-08-06
Item 1A. Risk Factors
material weaknesses. A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that3 matches in this document -
CTMX CytomX Therapeutics, Inc. 10-Q 2026-05-07
Item 1A. Risk Factors
material weaknesses. A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that3 matches in this document -
CTMX CytomX Therapeutics, Inc. 10-K 2026-03-16
Item 1A. Risk Factors
material weaknesses. A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that5 matches in this document -
CTMX CytomX Therapeutics, Inc. 10-Q 2025-11-06
Item 1A. Risk Factors
material weaknesses. A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that4 matches in this document -
CTMX CytomX Therapeutics, Inc. 10-Q 2025-08-07
Item 1A. Risk Factors
material weaknesses. A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that4 matches in this document -
CTMX CytomX Therapeutics, Inc. 10-Q 2025-05-12
Item 1A. Risk Factors
material weaknesses. A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that4 matches in this document
Page 1 of 1 · 7 documents